- Researchers for MOSAIC2 investigated atropine concentrations in controlling myopia progression in European children.
- Low-concentration atropine eye drops may have proportional treatment effects relative to untreated myopia progression.
- Atropine treatment benefits may be greater for patients with higher myopia progression, especially in slower-progressing European populations.
- Further studies are needed to assess long-term outcomes and treatment protocols for different demographic groups.
Source: JAMA Ophthalmology
